BUHLMANN Diagnostics Corp is proud to release the third edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this edition,
Continue Reading
Author: Collin Shaw
Digestive Diseases Week (DDW) 2017 BUHLMANN Diagnostics Corp Booth: #1925 May 06 - 09, 2017 | McCormick Place | Chicago, IL Learn More Click & Contact DDW 2017 BUHLMANN Team Connect with our team ahead of time, learn more about our Calprotectin Assays or schedule a meeting! Collin Shaw, VP of Business Development Jennifer Stuart, Technical
Continue Reading
BÜHLMANN fCAL® turbo is for Research Use Only. Not to be used in diagnostic procedures. Health Canada License: 96808 BÜHLMANN fCAL® turbo Stool extracts used in the BÜHLMANN fCAL® turbo on clinical chemistry analyzers can be applied without any concern of system contamination. BÜHLMANN investigated this new sample matrix with the goal to exclude potential risks.
Continue Reading
fCAL® turbo de BÜHLMANN Santé Canada Licence: 96808 English Version Entretien Avec Yvonne Schallberger, Bioanalytica Lucerne Madame Schallberger, vous avez dernièrement choisi d’utiliser le nouveau test fCAL® turbo de BÜHLMANN. Ce test s’adapte parfaitement sur des équipements de chimie clinique et permet l’analyse la calprotectine dans les selles en environ 10 minutes. Pourriez-vous nous indiquer les
Continue Reading
BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 French Version Interview with Yvonne Schallberger, Bioanalytica Lucerne Mrs. Schallberger, you recently decided to introduce the new calprotectin assay, BÜHLMANN fCAL® turbo, which offers a calprotectin result in random access mode on all USUAL
Continue Reading
BÜHLMANN's Kinase Inhibition Assay has been utilized in several publications in various fields of study such as drug discovery, cancer research, autoimmune disease research, and more. Several key kinases that are molecular targets in drug discovery, such as PI3Kγ and PI3Kδ, SYK, BTK are main components in the basophil activation signaling pathways. Our Assay has been
Continue Reading
BÜHLMANN Neuroimmunology Assays Simple, Esoteric Testing for Important Neuroimmune Biomarkers The BÜHLMANN Neuroimmunology product line is a list of robust assays for simple, esoteric testing for important neuroimmune biomarkers and it is supported by numerous clinical publications. Learn More About: Benefits, Features and Highlights of BÜHLMANN Neuroimmunology Assays BÜHLMANN Assay Kit Citations- See how these assays were used
Continue Reading
Are you using BÜHLMANN products and want to leave a comment on Biocompare? BÜHLMANN offers a wide variety of products including ELISA kits, RIA kits, lateral flow assays, flow cytometry assays and turbidimetric assays. If you have used any of the assays in our product portfolio please share your experience with researchers around the world and you
Continue Reading
BÜHLMANN’s Kinase Inhibition Assay Testing Potency and Efficacy of Inhibitors of PI3K δ, PI3K γ, BTK and SYK Activity Biomarker assays are developed specifically for pharmacokinetic and pharmacodyamic (PK/PD) models during drug discovery and are often used to test efficacy and toxicity. Inhibitors of PI3K, BTK and SYK pathways are a large focus for pharmaceutical
Continue Reading
BUHLMANN Diagnostics Corp is proud to present the very first edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this
Continue Reading
